Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in Acute STEMI
NCT01529554Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Jan 2015
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of everolimus in ST elevation myocardial infarction (STEMI), sponsored by University of Zurich. Started Jan 2015; status: completed.
02
Drugs
everolimus
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01529554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529554.